MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Repligen Corporation Total Non Current Liabilities 2011-2026 | RGEN
Annual Total Non Current Liabilities Repligen Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 701 M | 217 M | 233 M | 54.8 M | 292 M | 29.2 M | 127 M | 99.1 M | 4.71 M | 5.88 M | 3.46 M | 2.13 M | 584 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 701 M | 584 K | 136 M |
Quarterly Total Non Current Liabilities Repligen Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 709 M | 717 M | 715 M | 730 M | 706 M | 701 M | 700 M | 701 M | 162 M | 204 M | 192 M | 210 M | 217 M | - | 193 M | 233 M | 177 M | 80.6 M | 57.8 M | 54.8 M | 54.8 M | 54.8 M | 54.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 580 K | 577 K | 584 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 730 M | 577 K | 305 M |
Total Non Current Liabilities of other stocks in the Medical instruments industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
1.54 B | $ 70.29 | 0.17 % | $ 14 B |  USA |
 |
Atrion Corporation
ATRI
|
12.9 M | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | USA |
 |
Alcon
ALC
|
6.05 B | $ 74.63 | 0.09 % | $ 40.4 B |  Schweiz |
 |
Antares Pharma, Inc.
ATRS
|
30.2 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
1.16 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
74.1 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.99 B | - | -0.05 % | $ 10.3 B | USA |
 |
Baxter International
BAX
|
7.05 B | $ 16.65 | -0.18 % | $ 8.54 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
421 M | - | -0.02 % | $ 16.3 B | USA |
 |
BioLife Solutions
BLFS
|
41.7 M | $ 19.27 | -1.23 % | $ 888 M | USA |
 |
AtriCure
ATRC
|
261 M | $ 29.19 | 0.41 % | $ 1.39 B | USA |
 |
electroCore
ECOR
|
1.42 M | $ 7.04 | 3.53 % | $ 59.7 K | USA |
 |
Ekso Bionics Holdings
EKSO
|
11.2 M | $ 9.75 | 3.72 % | $ 23.7 M | USA |
 |
Glaukos Corporation
GKOS
|
87.4 M | $ 116.69 | 3.48 % | $ 5.65 B | USA |
 |
Haemonetics Corporation
HAE
|
405 M | $ 58.46 | 2.87 % | $ 2.94 B | USA |
 |
Harvard Bioscience
HBIO
|
58.5 M | $ 5.53 | 6.35 % | $ 245 M | USA |
 |
ICU Medical
ICUI
|
66.7 M | $ 122.99 | -0.26 % | $ 3.03 B | USA |
 |
InfuSystem Holdings
INFU
|
35 M | $ 9.43 | 1.51 % | $ 195 M | USA |
 |
iRhythm Technologies
IRTC
|
119 M | $ 117.22 | 0.36 % | $ 3.75 B | USA |
 |
Isoray
ISR
|
621 K | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
418 M | $ 452.58 | 0.11 % | $ 162 B | USA |
 |
Repro Med Systems
KRMD
|
239 K | $ 4.26 | -1.39 % | $ 197 M | USA |
 |
LeMaitre Vascular
LMAT
|
19.3 M | $ 109.16 | 0.62 % | $ 2.47 B | USA |
 |
Masimo Corporation
MASI
|
56 M | $ 178.49 | -0.06 % | $ 9.51 B | USA |
 |
Microbot Medical
MBOT
|
760 K | $ 2.36 | -1.67 % | $ 108 M |  Israel |
 |
Milestone Scientific
MLSS
|
1.4 M | $ 0.29 | 1.9 % | $ 23.8 M | USA |
 |
Merit Medical Systems
MMSI
|
626 M | $ 67.81 | 0.16 % | $ 4.01 B | USA |
 |
Envista Holdings Corporation
NVST
|
1.91 B | $ 25.81 | - | $ 4.34 B | USA |
 |
Predictive Oncology
POAI
|
236 K | - | - | $ 31.1 M | USA |
 |
Pro-Dex
PDEX
|
9.93 M | $ 48.53 | -6.08 % | $ 160 M | USA |
 |
Pulse Biosciences
PLSE
|
6.72 M | $ 22.94 | -0.26 % | $ 1.55 B | USA |
 |
ResMed
RMD
|
1.05 B | $ 224.93 | 0.37 % | $ 32.9 B | USA |
 |
Retractable Technologies
RVP
|
2.38 M | $ 0.71 | 2.98 % | $ 21.3 M | USA |
 |
NeuroMetrix
NURO
|
917 K | - | 5.05 % | $ 9.02 M | USA |
 |
STAAR Surgical Company
STAA
|
12.5 M | $ 20.96 | 3.71 % | $ 1.04 B | USA |
 |
STERIS plc
STE
|
1.53 B | $ 219.97 | 0.58 % | $ 21.7 B | USA |
 |
Stereotaxis
STXS
|
1.65 M | $ 1.88 | -0.53 % | $ 171 M | USA |
 |
Teleflex Incorporated
TFX
|
2.77 B | $ 115.04 | -2.35 % | $ 5.13 B | USA |
 |
Utah Medical Products
UTMD
|
5.25 M | $ 62.93 | -0.3 % | $ 204 M | USA |
 |
West Pharmaceutical Services
WST
|
427 M | $ 256.85 | 0.8 % | $ 18.6 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
2.54 B | $ 11.64 | 0.09 % | $ 2.32 B | USA |
 |
AngioDynamics
ANGO
|
148 M | $ 9.84 | -4.56 % | $ 402 M | USA |
 |
Becton, Dickinson and Company
BDX
|
25 B | $ 155.32 | 0.52 % | $ 44.7 B | USA |
 |
Nephros
NEPH
|
1.61 M | $ 2.86 | -0.35 % | $ 29.7 M | USA |
 |
OraSure Technologies
OSUR
|
22.5 M | $ 3.08 | - | $ 226 M | USA |